6.7 DETERMINATION OF SAMPLE SIZE FOR ESTIMATING MEANS 189
increase the willingness to be screened. A treatment group of 138 women received a leaflet on screen-
ing that contained more information (average individual risk for cervical cancer, likelihood of positive
finding, the possibility of false positive/negative results, etc.) than the standard leaflet developed by
the British National Health Service that 136 women in a control group received. In the treatment group,
109 women indicated they wanted to have the screening test for cervical cancer while in the control
group, 120 indicated they wanted the screening test. Construct a 95 percent confidence interval for the
difference in proportions for the two populations represented by these samples.
6.6.3 Spertus et al. (A-20) performed a randomized single blind study for subjects with stable coronary
artery disease. They randomized subjects into two treatment groups. The first group had current
angina medications optimized, and the second group was tapered off existing medications and then
started on long-acting diltiazem at 180 mg/day. The researchers performed several tests to deter-
mine if there were significant differences in the two treatment groups at baseline. One of the char-
acteristics of interest was the difference in the percentages of subjects who had reported a history
of congestive heart failure. In the group where current medications were optimized, 16 of 49 sub-
jects reported a history of congestive heart failure. In the subjects placed on the diltiazem, 12 of
the 51 subjects reported a history of congestive heart failure. State the assumptions that you think
are necessary and construct a 95 percent confidence interval for the difference between the pro-
portions of those reporting congestive heart failure within the two populations from which we pre-
sume these treatment groups to have been selected.
6.6.4 To study the difference in drug therapy adherence among subjects with depression who received usual
care and those who received care in a collaborative care model was the goal of a study conducted
by Finley et al. (A-21). The collaborative care model emphasized the role of clinical pharmacists in
providing drug therapy management and treatment follow-up. Of the 50 subjects receiving usual care,
24 adhered to the prescribed drug regimen, while 50 out of 75 subjects in the collaborative care model
adhered to the drug regimen. Construct a 90 percent confidence interval for the difference in adherence
proportions for the populations of subjects represented by these two samples.
6.7 DETERMINATION OF SAMPLE SIZE
FOR ESTIMATING MEANS
The question of how large a sample to take arises early in the planning of any survey
or experiment. This is an important question that should not be treated lightly. To take
a larger sample than is needed to achieve the desired results is wasteful of resources,
whereas very small samples often lead to results that are of no practical use. Let us con-
sider, then, how one may go about determining the sample size that is needed in a given
situation. In this section, we present a method for determining the sample size required
for estimating a population mean, and in the next section we apply this method to the
case of sample size determination when the parameter to be estimated is a population
proportion. By straightforward extensions of these methods, sample sizes required for
more complicated situations can be determined.
Objectives The objectives in interval estimation are to obtain narrow intervals with
high reliability. If we look at the components of a confidence interval, we see that the
width of the interval is determined by the magnitude of the quantity
1reliability coefficient2* 1standard error of the estimator2